The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02• GutAlive®: Microbiota Collection and Transport in Anaerobic Conditions• From Discovery to Disease Prevention: How the Biose–Siolta Partnership is Advancing a New Generation of Live Biotherapeutics• A pioneering gut bacterium passes Europe’s food-safety review under the EU Novel Food Regulation•

Microbiome Times

mbiomics Announces Third Closing of Series A, Reaching €30 Million to Advance Microbiome Therapeutics
Finance

mbiomics Announces Third Closing of Series A, Reaching €30 Million to Advance Microbiome Therapeutics

APR 28, 2026
Freya Biosciences announces positive Phase 1 data for IVF-related embryo implantation failure
Clinical & Manufacturing

Freya Biosciences announces positive Phase 1 data for IVF-related embryo implantation failure

APR 16, 2026
Multi-strain probiotic therapy shows promise in preventing bacterial vaginosis recurrence
Biotics and Supplements

Multi-strain probiotic therapy shows promise in preventing bacterial vaginosis recurrence

MAR 24, 2026
Qiagen unveils new high-throughput benchtop automation system
Pharma & Human Health

Qiagen unveils new high-throughput benchtop automation system

MAR 20, 2026
Opella announces strategic partnership with Verb Biotics for development of next-generation probiotic strain
Biotics and Supplements

Opella announces strategic partnership with Verb Biotics for development of next-generation probiotic strain

MAR 13, 2026
Cmbio: Advancing Microbiome Innovation Through Digital Biology
Pharma & Human Health

Cmbio: Advancing Microbiome Innovation Through Digital Biology

MAR 5, 2026
Missing microbes in UK infant gut and probiotics highlighted by global microbiome atlas
Biotics and Supplements

Missing microbes in UK infant gut and probiotics highlighted by global microbiome atlas

MAR 5, 2026
How Oral Drugs and Nutrition impacts Microbiome: Realistic Dynamic In Vitro Microbiome Modeling
Gastrointestinal

How Oral Drugs and Nutrition impacts Microbiome: Realistic Dynamic In Vitro Microbiome Modeling

FEB 26, 2026
Global scientific paper establishes first consensus definition of gut health
Gastrointestinal

Global scientific paper establishes first consensus definition of gut health

FEB 20, 2026
Microbiotica Announces Impressive Results in its Phase 1b Trial of MB310 in Ulcerative Colitis
Editor's Choice

Microbiotica Announces Impressive Results in its Phase 1b Trial of MB310 in Ulcerative Colitis

FEB 11, 2026
Researchers Discover that Vaginal Bacteria Don’t Always Behave the Same Way
Pharma & Human Health

Researchers Discover that Vaginal Bacteria Don’t Always Behave the Same Way

FEB 5, 2026